Cleared Traditional

K163225 - AFIAS iFOB with AFIAS-50 (FDA 510(k) Clearance)

Aug 2017
Decision
264d
Days
Class 2
Risk

K163225 is an FDA 510(k) clearance for the AFIAS iFOB with AFIAS-50. This device is classified as a Automated Occult Blood Analyzer (Class II - Special Controls, product code OOX).

Submitted by Immunostics Inc., (Ocean, US). The FDA issued a Cleared decision on August 8, 2017, 264 days after receiving the submission on November 17, 2016.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.6550. The Automated Test System Is Intended For The Qualitative Detection Of Fecal Occult Blood In Feces By Professional Laboratories. The Automated Test Is Used For The Determination Of Gastrointestinal Bleeding..

Submission Details

510(k) Number K163225 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 17, 2016
Decision Date August 08, 2017
Days to Decision 264 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code OOX - Automated Occult Blood Analyzer
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.6550
Definition The Automated Test System Is Intended For The Qualitative Detection Of Fecal Occult Blood In Feces By Professional Laboratories. The Automated Test Is Used For The Determination Of Gastrointestinal Bleeding.